Litigation Details for Pfizer Inc. v. Sun Pharmaceutical Industries Limited (D. Del. 2017)
✉ Email this page to a colleague
Pfizer Inc. v. Sun Pharmaceutical Industries Limited (D. Del. 2017)
Docket | ⤷ Sign Up | Date Filed | 2017-11-07 |
Court | District Court, D. Delaware | Date Terminated | 2019-03-07 |
Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
Jury Demand | None | Referred To | |
Patents | 6,956,041; 6,965,027; 7,091,208; 7,265,221; 7,301,023; RE41,783 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Pfizer Inc. v. Sun Pharmaceutical Industries Limited
Biologic Drugs cited in Pfizer Inc. v. Sun Pharmaceutical Industries Limited
Details for Pfizer Inc. v. Sun Pharmaceutical Industries Limited (D. Del. 2017)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2017-11-06 | 1 | XR® that are not at issue: U.S. Patent Nos. 6,956,041 (expiring December 8, 2020); 6,965,027 (expiring…for infringement of United States Patent No. RE41,783 (the “’783 patent”). 2. This action …addressed U.S. Patent No. 6,965,027. The Orange Book also lists five additional patents for Xeljanz XR… The ’783 Patent 29. On September 28, 2010, the USPTO issued the ’783 patent, titled “Pyrrolo…pyrimidine Compounds.” The ’783 patent is a reissue of U.S. Patent No. | External link to document | |
2017-11-06 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE41,783 E. (crb) (Entered: …2017 7 March 2019 1:17-cv-01597 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |